BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06757634-completion@plaintrial.com
DTSTAMP:20261027T172536Z
DTSTART;VALUE=DATE:20281230
SUMMARY:Phase 3 Study of Gedatolisib as First-Line Treatment for Patients W
 ith HR-Positive\, HER2-Negative Advanced Breast Cancer (VIKTORIA-2) — es
 timated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06757634
URL:https://plaintrial.com/trial/NCT06757634
END:VEVENT
END:VCALENDAR